Prof Stuart Roberts
Prof Stuart Roberts is the Head of Hepatology and a consultant gastroenterologist at The Alfred.
Having completed a Hepatology Fellowship at the Mayo Clinic in the USA, Professor Roberts was awarded a Doctorate of Medicine by the University of Melbourne for his liver research.
More recently, he completed a Master of Public Health at Monash University with High Distinction.
His main research interests are hepatocellular carcinoma, viral hepatitis, autoimmune hepatitis, fatty liver disease, and non-invasive markers of liver disease.
He has been Principal Investigator in over 165 sponsored and investigator-initiated clinical trials from phase I - IV. Professor Roberts has published more than 170 original articles across a range of high-impact journals including the New England Journal of Medicine, Lancet, Annals of Internal Medicine, Gastroenterology, Gut, Hepatology, and Journal of Hepatology.
Most significant trial
The Phase III randomised controlled trial of sofosbuvir and velpatasvir in patients with chronic hepatitis C genotype 3 infection. This was published in the New England Journal of Medicine and is now the standard of care for the vast majority of patients with chronic hepatitis C.